Trials
Search / Trial NCT06424938

Postoperative Analgesia in Major Gynecological Cancer Surgeries

Launched by DUYGU AKYOL · May 17, 2024

Apply for Trial

Trial Information

Current as of March 14, 2025

Not yet recruiting

Keywords

Postoperative Analgesia Periferic Nerve Block Neuraxial Block

ClinConnect Summary

Our study was designed as a prospective randomized study. The investigators evaluated the analgesia methods used in patients undergoing surgery for gynecologic cancer between May 2024 and December 2024. The investigators evaluated the effect of epidural block or erector spina plan block on postoperative analgesia, opioid use and mobilization.

Group 1: Epidural block group Group 2: Group with erector spina plan block

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • • Patients who will undergo open abdominal surgery
  • • Patients with ASAII-III
  • • Those between the ages of 30-70
  • • Patients who are fully oriented and able to cooperate
  • Exclusion Criteria:
  • • Patients with ASAIV-V
  • • Presence of active infection in the area where the block will be applied
  • • Patients younger than 30 years old
  • • Patients with BMI \> 40
  • • Patients who are allergic to bupivacaine
  • • Chronic analgesic use

About Duygu Akyol

Duygu Akyol is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative study designs and rigorous protocols. With a strong emphasis on ethical standards and regulatory compliance, Duygu Akyol leads multidisciplinary teams in the execution of clinical trials across various therapeutic areas. By fostering collaboration with healthcare professionals and leveraging cutting-edge technologies, the organization aims to accelerate the development of new therapies while ensuring the safety and well-being of participants. Their mission is to contribute to the advancement of science and medicine, ultimately enhancing the quality of life for patients worldwide.

Locations

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0